This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsDispensa Group（DISP）株式概要Dispensa Group Plc, a consumer brands company, acquires, integrates, and digitizes food producers. 詳細DISP ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6報酬当社が推定した公正価値より95.7%で取引されている リスク分析UK市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( £1M )最新の財務報告は6か月以上前のものである すべてのリスクチェックを見るDISP Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW486,852 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA486,852 investors already sharing narrativesYour Fair ValueUK£Current PriceUK£0.001820.5% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-3m4m2016201920222025202620282031Revenue UK£4.4mEarnings UK£131.7kAdvancedSet Fair ValueView all narrativesDispensa Group Plc 競合他社Roebuck Food GroupSymbol: AIM:RFGMarket cap: UK£26.3mVirgin Wines UKSymbol: AIM:VINOMarket cap: UK£13.3mNaked WinesSymbol: AIM:WINEMarket cap: UK£50.3mFinatis Société AnonymeSymbol: ENXTPA:FNTSMarket cap: €7.7m価格と性能株価の高値、安値、推移の概要Dispensa Group過去の株価現在の株価UK£0.001852週高値UK£0.1252週安値UK£0.0022ベータ01ヶ月の変化-41.67%3ヶ月変化-94.62%1年変化-98.37%3年間の変化n/a5年間の変化n/aIPOからの変化-98.15%最新ニュースお知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdomお知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£6.76m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (UK£6.76m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).New Risk • Jan 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (UK£12.5m market cap, or US$15.8m).Buying Opportunity • Jan 13Now 28% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be UK£0.038, however this is not to be taken as a buy recommendation but rather should be used as a guide only.最新情報をもっと見るRecent updatesお知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdomお知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£6.76m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (UK£6.76m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).New Risk • Jan 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (UK£12.5m market cap, or US$15.8m).Buying Opportunity • Jan 13Now 28% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be UK£0.038, however this is not to be taken as a buy recommendation but rather should be used as a guide only.お知らせ • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.Board Change • Nov 01Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.分析記事 • Sep 12Calculating The Intrinsic Value Of Zamaz plc (LON:ZAMZ)Key Insights Using the 2 Stage Free Cash Flow to Equity, Zamaz fair value estimate is UK£0.038 Current share price of...お知らせ • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.New Risk • Jun 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (UK£56.9m market cap, or US$71.4m).お知らせ • Feb 07An unknown buyer acquired a 5% stake in Zamaz plc (LSE:ZAMZ) from Atlas Capital Markets LLC for £3.7 million.An unknown buyer acquired a 5% stake in Zamaz plc (LSE:ZAMZ) from Atlas Capital Markets LLC for £3.7 million on February 6, 2023. Atlas sold 35.33 million shares, representing approximately 5% stake for 10.45 pence cash per share.An unknown buyer completed the acquisition of a 5% stake in Zamaz plc (LSE:ZAMZ) from Atlas Capital Markets LLC on February 6, 2023.お知らせ • Feb 02+ 2 more updatesZamaz plc Appoints Elena Schiavio as Chief Financial OfficerZamaz plc announced that Elena Schiavio has been appointed Chief Financial Officer (Non-Board). She has taken over the role from Jean-Christophe Agnésina who is continuing to work with the Group in a consulting capacity. Elena, an Italian chartered accountant, has more than 20 years of experience in financial administration and an extensive background of working within listed companies, having held multiple CFO positions. She also has considerable international tax, HR, corporate reorganisation and business restructuring experience, working in both Italy and London. She holds a degree in Economics from University Cattolica Sacro Cuore, and a Master's degree from University LIUC, Castellanza.お知らせ • Jan 17Maximum Return Systems Group acquired 13.28% stake in Zamaz plc (LSE:ZAMZ) from A. Khorassani.Maximum Return Systems Group acquired 13.28% stake in Zamaz plc (LSE:ZAMZ) from A. Khorassani on January 16, 2023. Maximum Return Systems Group completed the acquisition of 13.28% stake in Zamaz plc (LSE:ZAMZ) from A. Khorassani on January 16, 2023.お知らせ • Jan 06+ 1 more updateZamaz plc, Annual General Meeting, Jan 31, 2023Zamaz plc, Annual General Meeting, Jan 31, 2023, at 11:00 Coordinated Universal Time. Location: the Company's Administrative Offices, 50 London United KingdomBoard Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Martin Hugh Groak was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 18Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Martin Hugh Groak was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 14Raj Unnikandeth Decides to Step-Down from Board of Directors of Zamaz plcZamaz plc announced that Raj Unnikandeth has decided to step-down from the board of directors of the Company (the "Board") with immediate effect.株主還元DISPGB Consumer RetailingGB 市場7D-36.4%-0.7%1.2%1Y-98.4%7.4%17.0%株主還元を見る業界別リターン: DISP過去 1 年間で7.4 % の収益を上げたUK Consumer Retailing業界を下回りました。リターン対市場: DISPは、過去 1 年間で17 % のリターンを上げたUK市場を下回りました。価格変動Is DISP's price volatile compared to industry and market?DISP volatilityDISP Average Weekly Movement25.8%Consumer Retailing Industry Average Movement3.6%Market Average Movement5.1%10% most volatile stocks in GB Market10.4%10% least volatile stocks in GB Market2.7%安定した株価: DISPの株価は、 UK市場と比較して過去 3 か月間で変動しています。時間の経過による変動: DISPの 週次ボラティリティ は、過去 1 年間で14%から26%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト2019n/aDaniele Tommaso Besnatiwww.dispensagroup.comもっと見るDispensa Group Plc 基礎のまとめDispensa Group の収益と売上を時価総額と比較するとどうか。DISP 基礎統計学時価総額UK£1.25m収益（TTM）-UK£2.61m売上高(TTM)UK£4.38m0.3xP/Sレシオ-0.5xPER（株価収益率DISP は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計DISP 損益計算書（TTM）収益UK£4.38m売上原価UK£2.63m売上総利益UK£1.76mその他の費用UK£4.37m収益-UK£2.61m直近の収益報告Feb 28, 2023次回決算日該当なし一株当たり利益（EPS）-0.0037グロス・マージン40.06%純利益率-59.63%有利子負債／自己資本比率0%DISP の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/03/20 16:02終値2024/03/20 00:00収益2023/02/28年間収益2022/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Dispensa Group Plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.
お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom
お知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.
New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£6.76m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (UK£6.76m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).
New Risk • Jan 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (UK£12.5m market cap, or US$15.8m).
Buying Opportunity • Jan 13Now 28% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be UK£0.038, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.
お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom
お知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.
New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£6.76m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (UK£6.76m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).
New Risk • Jan 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (UK£12.5m market cap, or US$15.8m).
Buying Opportunity • Jan 13Now 28% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be UK£0.038, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.
Board Change • Nov 01Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.
分析記事 • Sep 12Calculating The Intrinsic Value Of Zamaz plc (LON:ZAMZ)Key Insights Using the 2 Stage Free Cash Flow to Equity, Zamaz fair value estimate is UK£0.038 Current share price of...
お知らせ • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.
New Risk • Jun 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (UK£56.9m market cap, or US$71.4m).
お知らせ • Feb 07An unknown buyer acquired a 5% stake in Zamaz plc (LSE:ZAMZ) from Atlas Capital Markets LLC for £3.7 million.An unknown buyer acquired a 5% stake in Zamaz plc (LSE:ZAMZ) from Atlas Capital Markets LLC for £3.7 million on February 6, 2023. Atlas sold 35.33 million shares, representing approximately 5% stake for 10.45 pence cash per share.An unknown buyer completed the acquisition of a 5% stake in Zamaz plc (LSE:ZAMZ) from Atlas Capital Markets LLC on February 6, 2023.
お知らせ • Feb 02+ 2 more updatesZamaz plc Appoints Elena Schiavio as Chief Financial OfficerZamaz plc announced that Elena Schiavio has been appointed Chief Financial Officer (Non-Board). She has taken over the role from Jean-Christophe Agnésina who is continuing to work with the Group in a consulting capacity. Elena, an Italian chartered accountant, has more than 20 years of experience in financial administration and an extensive background of working within listed companies, having held multiple CFO positions. She also has considerable international tax, HR, corporate reorganisation and business restructuring experience, working in both Italy and London. She holds a degree in Economics from University Cattolica Sacro Cuore, and a Master's degree from University LIUC, Castellanza.
お知らせ • Jan 17Maximum Return Systems Group acquired 13.28% stake in Zamaz plc (LSE:ZAMZ) from A. Khorassani.Maximum Return Systems Group acquired 13.28% stake in Zamaz plc (LSE:ZAMZ) from A. Khorassani on January 16, 2023. Maximum Return Systems Group completed the acquisition of 13.28% stake in Zamaz plc (LSE:ZAMZ) from A. Khorassani on January 16, 2023.
お知らせ • Jan 06+ 1 more updateZamaz plc, Annual General Meeting, Jan 31, 2023Zamaz plc, Annual General Meeting, Jan 31, 2023, at 11:00 Coordinated Universal Time. Location: the Company's Administrative Offices, 50 London United Kingdom
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Martin Hugh Groak was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 18Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Martin Hugh Groak was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 14Raj Unnikandeth Decides to Step-Down from Board of Directors of Zamaz plcZamaz plc announced that Raj Unnikandeth has decided to step-down from the board of directors of the Company (the "Board") with immediate effect.
